Home Tags Drug Development
Drug Development Related Content
Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.
The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.
Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.
New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.
A study recently identified 21 existing drugs that could improve the effect of remdesivir.
Scientists at the University of Cambridge have discovered a genetic variant that acts as a natural epidural, explaining why some women do not need pain relief during childbirth.
Scientists from the University of Edinburgh and Max Planck Institute for Biology of Ageing identify blood iron levels as an ageing factor.
A promising idea for lung cancer treatment has been developed by researchers at Lund University.
There is more positive news regarding remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19.
EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.
Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.